October 15, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, rm Rockville, MD 20852
|
|
- Willa Bryan
- 8 years ago
- Views:
Transcription
1 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, rm Rockville, MD RE: Current Good Manufacturing Practice and Hazard Analysis and Risk-Based Preventive Controls for Human Food: Preamble Section X.B.5. Food Sector Study and the Definitions of Small Business and Very small business, Proposed Definitions. [Docket No. FDA N-0920, 78 Fed. Reg. 3646, & 3800 (2013)] The Center for Science in the Public Interest (CSPI) thanks you for the opportunity to comment on the proposed rule to implement 418 of the Food, Drug, and Cosmetic Act of 1938 (FDCA) as amended by section 103 of the FDA Food Safety Modernization Act (FSMA). CSPI is a nonprofit health advocacy and education organization focused on food safety, nutrition, and alcohol issues. CSPI is supported principally by the 900,000 subscribers to its Nutrition Action HealthLetter and by foundation grants. We accept no government or industry funding. SUMMARY This comment covers the definition of very small business under the proposed rule. The definition will have a significant impact on public health and consumer safety because very small businesses can be exempted from the preventive food safety plans that other facilities must implement. For that reason, CSPI supports the defining a very small business as one that has less than $250,000 in total annual sales of food, adjusted for inflation. Statutory authority to define very small business must be strictly and narrowly construed because of the definition s impact on public health and safety. The definition that is most consistent with normal rules of statutory interpretation is a business with less than $250,000 in total annual sales.
2 Page 2 The Tester Amendment controls how very small business may be defined. If the term is defined as a business with less than $500,000 or $1 million in total annual sales of food it would o conflict with the structure of the Tester Amendment; o render provisions in the Tester Amendment superfluous; and o be inconsistent with the intent of the Tester Amendment. Defining very small business to mean a business with less than $250,000 in total annual sales most closely follows the structure, gives effect to every provision, and is most consistent with the purpose of the Tester Amendment. COMMENT FSMA is designed to enable the Food and Drug Administration (FDA) to better protect public health by focusing on preventing food safety problems rather than reacting to them after they occur. 1 This is in keeping with FDA s primary mission of protecting public health as described in 1003 of the FDCA. The proposed rule on Current Good Manufacturing Practice and Hazard Analysis and Risk-Based Preventive Controls for Human Food [Docket No. FDA-2011-N-0920] is intended to implement some of the public health programs and consumer protections embodied in FSMA and reflected in FDA s underlying mission statement. Due to the broad scope of the proposed rule, CSPI is providing this comment on the definition of very small business separately from comments we will submit on other provisions. Additionally, we believe how FDA defines very small business will have a significant impact on public health and consumer safety, a factor further justifying an individualized comment. We conclude that within the options offered FDA may only define the term as meaning a business that has less than $250,000 in total annual sales of food, adjusted for inflation. In support of this conclusion we offer the following comments with regard to The limited nature of FDA s discretion to define an exemption to public health and safety rules. Why options 2 and 3 are unacceptable given the statutory structure and intent of 418(l) of the FDCA (the Tester Amendment). Reasons for adopting a less than $250,000 in total annual sales threshold to define very small business. 1 Current Good Manufacturing Practice and Hazard Analysis and Risk-Based Preventive Controls for Human Food, proposed rule, 78 Fed. Reg. 3646, 3650 (Jan. 16, 2013).
3 Page 3 A. Agency has limited discretion in how it defines the term very small business. As an initial matter, we believe the only viable definition among those made available by the rule is that a very small business will have less than $250,000 in total annual sales of food. This is because well-established canons of statutory interpretation apply to FDA s exercise of its authority to exempt some food facilities from the full requirements of the preventive controls rule. FDA does not have unfettered discretion in how it defines the term very small business. Agencies are required to strictly and narrowly interpret statutory exemptions particularly when they affect public health and safety. 2 In this case, the definition will govern when a food facility may be exempt from the preventive controls rule under section 103(c)(1)(D) of FSMA or is required to comply with modified requirements in lieu of those covered by subsections (a) through (i) and (n) of 418 of the FDCA. As a practical matter there is little to distinguish between the exemption and modified requirements in this instance. 3 A very small business will be exempt from complying with FSMA s preventive food safety provisions in either case. As a consequence, consumers could be at greater or lesser risk depending on how FDA defines the term. FDA estimates the difference in the definitions will expose consumers to between 4,800 and 19,200 additional illnesses each year from food the rule would have regulated if there were no exemptions. 4 Since the definition exempts food facilities from the requirement to implement a preventive food safety program, FDA is required to apply the exemption to as narrow a subset of facilities as possible consistent with FSMA s instructions. FDA does this if it adopts the less than $250,000 in annual sales threshold for defining very small business. B. Options 2 and 3 for defining very small business lead to conflicts between statute s provisions (l) of the FDCA, the Tester Amendment, controls how FDA may define very small business. The preamble to the rule requests comment on three options for defining very small business for purposes of the Tester Amendment and other provisions in 2 USV Pharmaceutical Corporation v. Richardson, 461 F.2d 223, (4th Cir., 1972)(citing the principle that statutory exemptions, particularly as applied to statutes concerned with public health and safety, are to be strictly and narrowly construed ). 3 This view is further supported by the statutory text. While the subsection is headed Modified Requirements for Qualified Facilities in paragraph (1), its subheading in paragraph (2) for how these facilities are treated by the provision clearly reads Exemption. 4 Analysis of Economic Impact, D.1.b. (Table 4 Estimated Dollar Burden Attributable to FDA- Regulated Food Under the Scope of This Proposed Rule-Making).
4 Page The proposed rule requires food facilities to implement preventive controls that significantly minimize or eliminate the occurrence of foodborne hazards. 5 The Tester Amendment carves out two classes of qualified facilities based on their annual sales and marketing methods that may operate under modified rules. A qualified facility may be (1) a very small business or (2) a business with limited annual sales provided a majority of its sales are made directly to qualified endusers. 6 This structure controls how FDA must define very small business, and because average sales of less than $500,000 is used in the statute to define a facility with limited annual sales, the only reasonable definition of very small business is option 1, less than $250,000 in total annual sales. 7 The alternatives lead to a number of problems in implementing 418(l). Options 2 and 3 would define very small business to mean a business with less than $500,000 or $1 million in total annual sales respectively. These amounts would equal or exceed the amount allowed for qualified facilities with limited annual sales. As a result, those options overwhelm the Tester Amendment s structure and defeat its purpose. We offer the following reasons for this view. 2. Options 2 and 3 are inconsistent with statutory structure of 418(l) of the FDCA The major objection to the higher sales limits in options 2 and 3 is that they are inconsistent with the statutory structure of the Tester Amendment. A principle of statutory interpretation holds that an agency cannot construe an exemption in a way that nullifies other conditions of its application. 8 Options 2 and 3 run afoul of this principle because of how the Tester Amendment treats the two classes of qualified facilities. The first classification automatically applies based on FDA s definition of very small business. The other applies only if the facility owner agrees to operate under the restrictions set out in 418(l)(1)(C) of the FDCA. The outcome 5 Food, Drug, and Cosmetic Act of , 21 U.S.C. 350g (2013) 6 A qualified end-user is defined as (1) the consumer of the food; or (2) restaurants or retail food establishments that are located in the same state as the qualified facility or within a radius of 275 miles of it provided they sell the food directly to consumers. Other conditions that apply are that the size of the facility has to take into account the income and practices of any subsidiary or affiliated business. 418(l)(1)(B) & (C) and (4)(B). 7 CSPI agrees with FDA s decision to define very small business in terms of total sales rather than other factors such as volume of production or number of employees. 8 USV Pharmaceutical Corporation, 461 F.2d 227, Agencies must avoid interpretations that are inconsistent with the structure of the statute, or that render any of its provisions superfluous. See, the list of textual integrity canons in William N. Eskridge, Philip P. Frickey & Elizabeth Garrett, Cases and Materials on Legislation: Statutes and the Creation of Public Policy app. A, 20 (3rd Ed. 2001), Market Company v. Hoffman, 101 U.S. 112, (1879)(a cardinal rule of statutory construction holds that a statute must be construed so that no clause, sentence or word is rendered superfluous, void or insignificant)(more recently cited in Duncan v. Walker, 533 U.S. 167, 174 (2001)).
5 Page 5 of applying either option 2 or 3 is the improper nullification of 418(l)(1)(C) of the FDCA by taking away any incentive for a facility owner to qualify under that provision. This happens because they subsume the class of qualified facilities with limited annual sales into the class of very small businesses. That impacts the choice between the classifications of qualified facilities in two ways. In terms of sales, the options match or exceed the limit of less than $500,000 that applies to a facility with limited annual sales. In terms of burdens, a facility with limited annual sales must keep additional records showing a majority of its food is sold to qualified endusers. 9 In contrast, a very small business under options 2 and 3 can earn as much or more from unrestricted sales while partially avoiding recordkeeping burdens. Given those advantages, it is unlikely any facility owner would opt for classification as a qualified facility with limited annual sales, rendering 418(l)(1)(C) of the FDCA superfluous. Since Options 2 and 3 violate well-established principles of statutory interpretation, the only reasonable definition is that a small business is one with less than $250,000 in total annual sales. 3. Options 2 and 3 are inconsistent with statutory intent of 418(l) of the FDCA. Options 2 and 3 are also inconsistent with the statutory intent of 418(l) of the FDCA. Based on comments by Tester Amendment supporters and by Senator Jon Tester, the amendment s author, the provision contemplates different safety thresholds at different product distribution levels. During development of the legislation, Tester Amendment supporters argued that FSMA imposes an unreasonable regulatory burden on small businesses that exceeds the public health benefit from universal compliance with its most rigorous provisions. 10 Senator Tester, meanwhile, viewed the close producer-customer relationship as a control for safety when a business is smaller than $500,000 in sales and primarily sells directly to consumers or locally to food retailers and restaurants. 11 If these rationales cover the same facilities, as would happen if the definitions overlap, then the first contradicts the second. Either the risk is present but too small to regulate efficiently or a system of direct and local sales controls the risk making it unnecessary to regulate. The only reasonable interpretation of the Tester Amendment, therefore, 9 While FDA will not require qualified facilities to submit financial records, proposed (e) of the rule requires them to maintain and, if requested, make available to FDA all records that support the facility s self-certification of its status. 10 Letter from 87 organizations representing local food interests to the U.S. Senate (Apr. 7, 2010)(Support Fresh, Safe Local Food in the Food Safety Bill) Cong. Rec. S8010 (daily ed. Nov. 18, 2010)(statement of Sen. Tester)(the geographical area is limited to the state where the qualified facility is located or to any retailer/restaurant within 275 miles of the qualified facility).
6 Page 6 anticipates that a very small facility is overly burdened regardless of how it markets product, but that a transition occurs at some point to account for the weakening of the producer-customer relationship as a business grows. Food processors in that transition can be relied upon to operate safely only if they deal directly with their customers. Under this logic, a reasonable place for FDA to set that transition is less than $250,000 in total annual sales. C. Option 1 fits most closely with structure and intent of 418(l) of the FDCA. The objections to options 2 and 3 would not apply to the definition under option 1 of very small business as meaning a facility with less than $250,000 in annual sales. That makes option 1 the more reasonable approach to implementing the Tester Amendment. It most closely follows the statutory structure of 418(l) and the intent of its author by clearly distinguishing between the two types of qualified facilities. Furthermore, applying option 1 would provide a rule that properly aligns incentives with the Tester Amendment s statutory scheme and the assumptions underlying it. Option 1 treats both classes of qualified facilities more equitably than options 2 and 3. A very small business threshold of less than $250,000 can be understood as applying to either type of qualified facility. Following the logic of the Tester Amendment a qualified facility selling below the threshold does not produce enough product for federal regulation to be efficient. 12 FDA estimates this threshold covers less than half a percent of food falling within the scope of the preventive controls rule. A processor that engages in sales above this threshold, meanwhile, does not of necessity lose its status as a qualified facility. The facility may retain its status if it agrees to marketing restrictions and additional recordkeeping requirements designed to ensure a majority of the food sold goes directly to consumers. These conditions track Senator Tester s logic that the close relationship of the producer to the consumer that exists in a direct sales situation is sufficient to ensure a safe product. 13 The result is a fair rule that provides opportunities for very small businesses to grow without abruptly losing their status as qualified facilities. 12 An exemption based on regulatory efficiency is not unheard of. FDA has set this kind of regulatory threshold in other circumstances. For example, FDA cited efficiency in exempting farms with fewer than 3,000 laying hens from its shell egg rule for control of Salmonella Enteritidis. The number of farms with fewer than 3,000 hens is large at 65,000, but the impact of the exemption is small at less than 1 percent of supply. Prevention of Salmonella Enteritidis in Shell Eggs During Production, Storage, and Transportation, 74 Fed. Reg , (July 9, 2009). 13 While the logic is debatable, it clearly animates the Tester Amendment and so is cited here merely for the proposition that option 1 is more closely aligned with the amendment than the other options.
7 Page 7 The purpose of FSMA is to improve FDA s ability to prevent, detect, and respond to food safety problems by establishing a system that is science and riskbased, accountable to consumers, transparent and focused on prevention. 14 In order to gain passage of FSMA, the Senate amended the original bill by adding a narrow exemption to address concerns over regulatory burdens on very small businesses. The Tester Amendment carved out two classes of qualified facilities for exemption from the full impact of the preventive controls in section 103 of FSMA. Inherent to arguments for the Tester Amendment is an assumption that the exempted facilities will have a very small impact on public health. That underlying assumption is rapidly weakened as more facilities are exempted under each option for defining the term very small business. FDA should not allow what was intended as a narrow exemption to swallow up the public health and food safety purpose of the larger law. Yet, that is precisely what happens if FDA adopts a broad definition of very small business as proposed in options 2 and 3. For the reasons stated above, FDA must define very small businesses as being food facilities smaller than $250,000 in annual sales. Sincerely, David W. Plunkett Senior Staff Attorney, Center for Science in the Public Interest Cong. Rec. S2693 (2010) (statement of Sen. Durbin on introduction of S. 510).
Guidance for Industry. Further Amendments to General Regulations of the Food and Drug Administration to Incorporate Tobacco Products
Guidance for Industry Further Amendments to General Regulations of the Food and Drug Administration to Incorporate Tobacco Products Small Entity Compliance Guide Written comments and suggestions may be
More informationEgg Safety; Proposed Rule for Prevention of Salmonella Enteritidis in Shell
1 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Parts 16 and 118 [Docket Nos. 1996P 0418, 1997P 0197, 1998P 0203, and 2000N 0504] RIN 0910 AC14 Egg Safety; Proposed Rule for
More informationU.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) March 2006 Compliance
Guidance for Industry Prescription Drug Marketing Act Donation of Prescription Drug Samples to Free Clinics U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation
More informationGuidance for Industry Part 11, Electronic Records; Electronic Signatures Scope and Application
Guidance for Industry Part 11, Electronic Records; Electronic Signatures Scope and Application U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research
More informationFINAL GUIDANCE. For questions on the content of this guidance, contact Advisory Committee Oversight and Management Staff, at 301-796-8220.
Guidance for the Public, FDA Advisory Committee Members, and FDA Staff: Public Availability of Advisory Committee Members' Financial Interest Information and Waivers FINAL GUIDANCE Comments and suggestions
More informationGuidance for Industry
Guidance for Industry Questions and Answers Regarding Registration of Food Facilities (Edition 2) Final Guidance Comments and suggestions regarding this document may be submitted at any time. Submit comments
More informationAvvo Legal Services and The Rules of Professional Conduct
Avvo Legal Services and The Rules of Professional Conduct Avvo Legal Services are designed to solve a simple yet vexing problem: how to make it easier for consumers and small businesses to get access to
More informationHow To Exempt From Reporting And Recordkeeping Requirements For Tv And Computer Monitors With Cathode Ray Tubes
Guidance for Industry and FDA Staff Exemption from Certain Reporting and Recordkeeping Requirements for Television Receivers and Computer Monitors with Cathode Ray Tubes Document issued on October 20,
More informationEclipsys Sunrise Clinical Manager Enterprise Electronic Medical Record (SCM) and Title 21 Code of Federal Regulations Part 11 (21CFR11)
Eclipsys Sunrise Clinical Manager Enterprise Electronic Medical Record (SCM) and Title 21 Code of Federal Regulations Part 11 (21CFR11) The title 21 code of federal regulations part 11 deals with an institutions
More informationRe: Docket No. FDA 2014 N 0339: Proposed Risk-Based Regulatory Framework and Strategy for Health Information Technology Report; Request for Comments
Leslie Kux Assistant Commissioner for Policy Food and Drug Administration Division of Docket Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: Docket
More informationReport of the Legislation Subcommittee. of the Franchise, Distribution and Licensing Committee. of the
Report of the Legislation Subcommittee of the Franchise, Distribution and Licensing Committee of the New York State Bar Association s Business Law Section November 10, 2009 Subcommittee Members: Thomas
More informationSUMMARY: The United States Small Business Administration (SBA) is increasing the
This document is scheduled to be published in the Federal Register on 12/06/2012 and available online at http://federalregister.gov/a/2012-29360, and on FDsys.gov BILLING CODE: 8025-01 SMALL BUSINESS ADMINISTRATION
More informationGuidance for Industry
Guidance for Industry Bar Code Label Requirements Questions and Answers (Question 12 Update) DRAFT GUIDANCE This guidance document is for comment purposes only. Submit comments on this draft guidance by
More informationDEPARTMENT OF HEALTH AND HUMAN SERVICES. Medicare, Medicaid, Children's Health Insurance Programs; Transparency Reports
This document is scheduled to be published in the Federal Register on 02/08/2013 and available online at http://federalregister.gov/a/2013-02572, and on FDsys.gov 1 DEPARTMENT OF HEALTH AND HUMAN SERVICES
More informationContains Nonbinding Recommendations
Guidance for Industry and FDA Staff Laser Products Conformance with IEC 60825-1 and IEC 60601-2-22; Guidance for Industry and FDA Staff (Laser Notice No. 50) Document issued on June 24, 2007 This document
More informationCase 2:10-md-02179-CJB-SS Document 14206 Filed 02/19/15 Page 1 of 7 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF LOUISIANA * * * * * * * *
Case 2:10-md-02179-CJB-SS Document 14206 Filed 02/19/15 Page 1 of 7 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF LOUISIANA In re: Oil Spill by the Oil Rig Deepwater Horizon in the Gulf of Mexico, on
More informationDivision of Swap Dealer and Intermediary Oversight
U.S. COMMODITY FUTURES TRADING COMMISSION Three Lafayette Centre 1155 21st Street, NW, Washington, DC 20581 Telephone: (202) 418-6700 Facsimile: (202) 418-5528 gbarnett@cftc.gov Division of Swap Dealer
More informationAgreements and Memoranda of Understanding Between the Food and Drug Administration and
This document is scheduled to be published in the Federal Register on 03/23/2012 and available online at http://federalregister.gov/a/2012-06969, and on FDsys.gov 4160-01-P DEPARTMENT OF HEALTH AND HUMAN
More informationRe: Comments on Proposed Regulations to Implement Section 307 (Prior Notice of Imported Food) of the Bioterrorism Act, Docket No.
April 2, 2003 Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, Maryland 20852 Re: Comments on Proposed Regulations to Implement Section 307 (Prior
More informationIDENTIFICATION OF CONTRACTS OF INSURANCE INSTRUMENT 2004
FSA 2004/58 IDENTIFICATION OF CONTRACTS OF INSURANCE INSTRUMENT 2004 Powers exercised A. The Financial Services Authority makes this instrument in the exercise of the power in section 157(1) (Guidance)
More informationGuidance for Industry
Guidance for Industry Expanded Access to Investigational Drugs for Treatment Use Qs & As DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding
More informationsections 201 and 206 of the Public Health Law and sections 363-a and 365-a(2) of the Social
Qualified Health Information Technology Entities Effective date: 2/15/12 Pursuant to the authority vested in the Department of Health and the Commissioner of Health by sections 201 and 206 of the Public
More information800 17th Street, NW Suite 1100, Washington, DC 20006
800 17th Street, NW Suite 1100, Washington, DC 20006 September 3, 2015 Mr. Andrew Slavitt Acting Administrator, Centers for Medicare & Medicaid Services Department of Health and Human Services Hubert H.
More informationTrade Member Discrimination, Marketing and Advertising: Discrimination in
LAW AND PUBLIC SAFETY DIVISION OF ALCOHOLIC BEVERAGE CONTROL Trade Member Discrimination, Marketing and Advertising: Discrimination in Terms of Sale; Disciplinary Proceedings: Penalty Schedule, definition
More informationFile Number S7-40-10 Proposed rules for implementing the conflict minerals provision of Section 13(p) of the Securities Exchange Act of 1934
BCE Inc. 1, carrefour Alexander-Graham-Bell Aile A-7 Verdun, QC H3E 3B3 Michel Lalande SVP General Counsel michel.lalande@bell.ca T: 514 391-8386 F: 514 766-8758 VIA ELECTRONIC SUBMISSION October 31, 2011
More informationGuidance for Industry What You Need To Know About Registration of Food Facilities Small Entity Compliance Guide
Guidance for Industry What You Need To Know About Registration of Food Facilities Small Entity Compliance Guide Additional copies are available from: Office of Compliance, HFS-607 Center for Food Safety
More informationBefore the Federal Communications Commission Washington, D.C. 20554 ) ) ) ) ) ) ) DECLARATORY RULING
Before the Federal Communications Commission Washington, D.C. 20554 In the Matter of Rules and Regulations Implementing the Telephone Consumer Protection Act of 1991 Request of ACA International for Clarification
More informationSTATE OF ARIZONA OFFICE OF THE ATTORNEY GENERAL
STATE OF ARIZONA OFFICE OF THE ATTORNEY GENERAL ATTORNEY GENERAL OPINION by TERRY GODDARD ATTORNEY GENERAL September 6, 2006 No. I06-003 (R06-024) Re: Amending Contracts of Certain School Employees to
More informationStructuring Physician Recruitment Arrangements in Accordance with the Stark II/Phase II Interim Final Rule
Structuring Physician Recruitment Arrangements in Accordance with the Stark II/Phase II Interim Final Rule Stacey A. Tovino satovino@central.uh.edu June 25, 2004 On March 26, 2004, the Centers for Medicare
More informationinterpretation of its Hazard Analysis Critical Control Point (I-IACCP) regulations for fish and fishery
DEPARTMENT OF HEALTH ANb HUMAN SERVICES Food and Drug Administration [Docket No. OOD-15551 Guidance for Industry on Refusal of Inspection or Access to HACCP Records Pertaining to the Safe and Sanitary
More informationGuidance for Industry ANDA Submissions Amendments and Easily Correctable Deficiencies Under GDUFA
Guidance for Industry ANDA Submissions Amendments and Easily Correctable Deficiencies Under GDUFA DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions
More informationThe statements made herein are our own and do not necessarily reflect the views of the Johns Hopkins University.
Johns Hopkins Center for a Livable Future 615 North Wolfe Street, W7010 Baltimore, MD 21205 January 4, 2013 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, rm.
More informationB-302973. October 6, 2004. The Honorable Lane Evans Ranking Minority Member Committee on Veterans Affairs House of Representatives
United States Government Accountability Office Washington, DC 20548 October 6, 2004 The Honorable Lane Evans Ranking Minority Member Committee on Veterans Affairs House of Representatives Subject: Veterans
More informationDecember 23,2003. Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, 20852
Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, 20852 RE: Comments to Docket No. 02W0276, Interim Final Rule on Registration of Food Facilities
More informationDetermination of Regulatory Review Period for Purposes of Patent Extension; XARELTO
This document is scheduled to be published in the Federal Register on 05/29/2014 and available online at http://federalregister.gov/a/2014-12349, and on FDsys.gov 4160-01-P DEPARTMENT OF HEALTH AND HUMAN
More informationDRAFT GUIDANCE. This guidance document is being distributed for comment purposes only. Document issued on: July 2015
Third-Party Auditor/Certification Body Accreditation for Food Safety Audits: Model Accreditation Standards Draft Guidance for Industry and Food and Drug Administration Staff DRAFT GUIDANCE This guidance
More informationDecember 7, 2000. financial holding companies to engage in new data processing and electronic activities. From: Staff 1
December 7, 2000 To: Board of Governors From: Staff 1 Subject: Proposal to allow financial holding companies to engage in new data processing and electronic activities. ACTION REQUESTED: Approval to request
More informationGuidance for Industry. Required Warnings for Cigarette Packages and Advertisements
Guidance for Industry Required Warnings for Cigarette Packages and Advertisements Small Entity Compliance Guide Written comments and suggestions may be submitted at any time for Agency consideration to
More informationGuidance for Industry
Guidance for Industry FDA Export Certificates Submit comments and suggestions regarding this document at anytime to Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane,
More informationGuidance for Industry DRAFT GUIDANCE
DSCSA Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs: How to Exchange Product Tracing Information Guidance for Industry DRAFT GUIDANCE
More informationDecember 23, 2009. Dear Commissioner Stevens:
December 23, 2009 The Honorable David H. Stevens Assistant Secretary for Housing-Federal Housing Commissioner U.S. Department of Housing and Urban Development Federal Housing Administration 451 Seventh
More informationGuidance for Industry. 21 CFR Part 11; Electronic. Records; Electronic Signatures. Time Stamps
Guidance for Industry 21 CFR Part 11; Electronic Records; Electronic Signatures Time Stamps Draft Guidance This guidance document is being distributed for comment purposes only. Comments and suggestions
More informationJanuary 18, 2011. Annual Funding Notice for Defined Benefit Plans. To Whom It May Concern:
Office of Regulations and Interpretations Employee Benefits Security Administration Room N-5655 U.S. Department of Labor 200 Constitution Avenue, NW Washington, DC 20210 January 18, 2011 Re: Annual Funding
More informationUNITED STATES BANKRUPTCY COURT EASTERN DISTRICT OF WISCONSIN. In re Case No. 07-27105 JAMES L. BORK and MICHELLE M. BORK, Chapter 7 Debtors.
UNITED STATES BANKRUPTCY COURT EASTERN DISTRICT OF WISCONSIN In re Case No. 07-27105 JAMES L. BORK and MICHELLE M. BORK, Chapter 7 Debtors. 1 MEMORANDUM DECISION ON TRUSTEE S OBJECTION TO EXEMPTION This
More informationMedical Devices; Cardiovascular Devices; Classification of the Esophageal Thermal Regulation
This document is scheduled to be published in the Federal Register on 08/18/2015 and available online at http://federalregister.gov/a/2015-20317, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN
More informationB-327192. July 28, 2015. The Honorable Orrin G. Hatch Chairman The Honorable Ron Wyden Ranking Member Committee on Finance United States Senate
441 G St. N.W. Washington, DC 20548 B-327192 July 28, 2015 The Honorable Orrin G. Hatch The Honorable Ron Wyden Committee on Finance United States Senate The Honorable Lamar Alexander The Honorable Patty
More informationFinal text of Durbin Amendment as contained in the Dodd Frank Act
Final text of Durbin Amendment as contained in the Dodd Frank Act SEC. 920. REASONABLE FEES AND RULES FOR PAYMENT CARD TRANSACTIONS. (a) REASONABLE INTERCHANGE TRANSACTION FEES FOR ELECTRONIC DEBIT TRANSACTIONS.
More informationNational Consumer Credit Protection Amendment (Credit Reform Phase 2) Bill 2012
Mr Christian Mikula Manager, Disclosure and International Unit Retail Investor Division The Treasury Langton Crescent PARKES ACT 2600 By email: creditphase2bill@treasury.gov.au 1 March 2013 National Consumer
More informationAMERICAN COUNCIL ON EDUCATION OFFICE OF THE PRESIDENT. February 22, 2011
AMERICAN COUNCIL ON EDUCATION OFFICE OF THE PRESIDENT Elizabeth M. Murphy, Secretary Securities and Exchange Commission 100 F Street NE Washington, DC 20549-1090 Re: Registration of Municipal Advisors
More informationUNITED STATES BANKRUPTCY COURT EASTERN DISTRICT OF MICHIGAN SOUTHERN DIVISION
UNITED STATES BANKRUPTCY COURT EASTERN DISTRICT OF MICHIGAN SOUTHERN DIVISION In re: Chapter 9 City of Detroit, Michigan, Case No. 13-53846 Debtor. Hon. Steven W. Rhodes / Order Granting the City s Motion
More informationClearing Agency Standards for Operation and Governance; File No. S7-08-11
BETTER M KETS TRANSPARENCY ACCOUNTABILITY GVERSIGHT April 29, 2011 Ms. Elizabeth M. Murphy Secretary Securities and Exchange Commission 100 F Street, NE Washington, DC 20549-1090 Re: Clearing Agency Standards
More informationSTATE OF CALIFORNIA DEPARTMENT OF INSURANCE 45 Fremont Street, 21st Floor San Francisco, California 94105 INITIAL STATEMENT OF REASONS
STATE OF CALIFORNIA DEPARTMENT OF INSURANCE 45 Fremont Street, 21st Floor San Francisco, California 94105 INITIAL STATEMENT OF REASONS Date: March 11, 2011 REG-2011-00002 SUITABILITY IN ANNUITY TRANSACTIONS
More informationOctober 27, 2014. Docket No. CFPB-2014-0019, RIN 3170-AA10 Home Mortgage Disclosure (Regulation C)
October 27, 2014 The Honorable Richard Cordray Director Consumer Financial Protection Bureau 1700 G Street NW Washington, DC 20006-4702 Monica Jackson Office of the Executive Secretary Consumer Financial
More information2014 IL App (2d) 130390-U No. 2-13-0390 Order filed December 29, 20140 IN THE APPELLATE COURT OF ILLINOIS SECOND DISTRICT
No. 2-13-0390 Order filed December 29, 20140 NOTICE: This order was filed under Supreme Court Rule 23 and may not be cited as precedent by any party except in the limited circumstances allowed under Rule
More informationFee Waivers INTRODUCTION CONTENTS FEES: THE RATIONALE
Number 2 Revised March 2009 Fee Waivers CONTENTS Introduction 1 Fees: the rationale 1 How the Act and Regulation apply to fees and fee waivers Assessment of fees 2 Fees for personal information 2 Payment
More informationPresidential Documents
Federal Register Vol. 58, No. 190 Presidential Documents Monday, October 4, 1993 Title 3 The President Executive Order 12866 of September 30, 1993 Regulatory Planning and Review The American people deserve
More informationOffice of Regulation Review (ORR) Submission regarding the Attorney General s Discussion Paper on Privacy protection in the private sector
Office of Regulation Review (ORR) Submission regarding the Attorney General s Discussion Paper on Privacy protection in the private sector The Office of Regulation Review (ORR) located within the Industry
More informationDetermination of Regulatory Review Period for Purposes of Patent Extension;
This document is scheduled to be published in the Federal Register on 12/15/2015 and available online at http://federalregister.gov/a/2015-31400, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN
More informationIMPLEMENTING THE RESTRICTION OF PENSIONS TAX RELIEF: NAPF SUBMISSION TO THE HMT/HMRC CONSULTATION
IMPLEMENTING THE RESTRICTION OF PENSIONS TAX RELIEF: NAPF SUBMISSION TO THE HMT/HMRC CONSULTATION Executive Summary The NAPF welcomes the Coalition Government s decision to adopt a tax regime based principally
More informationThis letter has been withdrawn. See Administrtor Interpretation 2010-1. September 8, 2006
U.S. Department of Labor Employment Standards Administration Wage and Hour Division Washington, D.C. 20210 This letter has been withdrawn. See Administrtor Interpretation 2010-1. September 8, 2006 FLSA2006-31
More informationU.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) September 2009 OTC
Guidance for Industry Labeling of Nonprescription Human Drug Products Marketed Without an Approved Application as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act: Questions
More informationIssuance of a Preferred Stock Dividend by the Federal Home Loan Mortgage Corporation
Issuance of a Preferred Stock Dividend by the Federal Home Loan Mortgage Corporation The Federal Home Loan Mortgage Corporation is authorized, under 12 U S.C. 1455(0.to *ssue a dividend of preferred stock
More informationGuidance for Industry
Guidance for Industry Formal Dispute Resolution: Scientific and Technical Issues Related to Pharmaceutical CGMP U.S. Department of Health and Human Services Food and Drug Administration Center for Drug
More informationBefore the Federal Communications Commission Washington, D.C. 20554 ) ) ) ) ) COMMENTS OF THE NATIONAL ASSOCIATION OF BROADCASTERS
Before the Federal Communications Commission Washington, D.C. 20554 In the Matter of Carriage of Digital Television Broadcast Signals: Amendment to Part 76 of the Commission s Rules CS Docket No. 98-120
More informationDRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.
Guidance for Industry Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media for Prescription Human and Animal Drugs and Biologics DRAFT GUIDANCE This guidance
More informationRe: Guidance for Industry Fees for Human Drug Compounding Outsourcing Facilities Under The Federal Food, Drug and Cosmetic Act
May 30, 2014 Division of Dockets Management (HFA-305) Food and Drug Administration Department of Health and Human Services 5630 Fishers Lane, Room. 1061 Rockville, Maryland 20852 [Docket No. FDA-2014-D-0329]
More informationExcess Benefit Transactions Under Section 4958 And Revocation Of Tax-Exempt Status
Excess Benefit Transactions Under Section 4958 And Revocation Of Tax-Exempt Status Originally published in the Spring 2009 issue of The Practical Tax Lawyer, published by ALI-ABA in cooperation with the
More informationLeadingAge NY Comments on Independence of LTC Consultant Pharmacists ( 483.60)
LeadingAge NY Comments on Independence of LTC Consultant Pharmacists ( 483.60) Introduction Please accept and consider the comments of LeadingAge NY on section 5.) Independence of LTC Consultant Pharmacists
More informationR-1407, RIN 7100-AD66
CHASE Miriam Frieden Associate General Counsel, Senior Vice President Chase Card Services April 14, 2011 By Electronic Mail Jennifer J. Johnson, Secretary Board of Governors of the Federal Reserve System
More informationDSCSA Implementation: Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers
DSCSA Implementation: Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for
More informationCHAPTER 3. LIFE, ACCIDENT, AND HEALTH INSURANCE AND ANNUITIES Subchapter QQ, Provider Network Contract Registration 28 TAC 3.9801 3.
Part I. Texas Department of Insurance Page 1 of 23 CHAPTER 3. LIFE, ACCIDENT, AND HEALTH INSURANCE AND ANNUITIES Subchapter QQ, Provider Network Contract Registration 28 TAC 3.9801 3.9805 1. INTRODUCTION.
More informationMAX WILLIAM BOURNE; KARISSA M. ROWLAND; JOSE L. SIMENTAL-FUENTES; JORGE GARCIA-FRAIJO, Petitioners,
IN THE ARIZONA COURT OF APPEALS DIVISION ONE MAX WILLIAM BOURNE; KARISSA M. ROWLAND; JOSE L. SIMENTAL-FUENTES; JORGE GARCIA-FRAIJO, Petitioners, v. THE HONORABLE CRANE McCLENNEN, Judge of the SUPERIOR
More informationq-1'08 date ofpublication in the Federal Register]. www.regulations.gov.
- - p p p p p DEPARTMENT OF HEALTH AND HUMAN SERVICES Display Date q-1'08 Food and Drug Administration [Docket No. FDA-2008-N-01831 Third-Party Certification Programs for Foods and Feeds; Request for Comments
More informationGuidance for Industry
Guidance for Industry Contract Manufacturing Arrangements for Drugs: Quality Agreements DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding
More informationooo- I542 (314 Brlngrng tnnovation to patient care worldwide April 23,2003
Dockets Manalgement Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852. RE: Docked+ Nos. 03D-0060,99D-1458,OOD-1538,OOD-1543,OOD-1542, and 000-l 539; Draft Guidance
More informationDepartment of Health and Human Services DEPARTMENTAL APPEALS BOARD. Civil Remedies Division
Department of Health and Human Services DEPARTMENTAL APPEALS BOARD Civil Remedies Division Marcia M. Snodgrass, APRN, Petitioner, v. Centers for Medicare & Medicaid Services. Docket No. C-14-1542 Decision
More informationMedical Device Data Systems, Medical Image Storage Devices, and Medical Image Communications Devices
Medical Device Data Systems, Medical Image Storage Devices, and Medical Image Communications Devices Draft Guidance for Industry and Food and Drug Administration Staff DRAFT GUIDANCE This guidance document
More informationApril 12, 2011 BY ELECTRONIC SUBMISSION. Elizabeth M. Murphy Secretary Securities and Exchange Commission 100 F Street, NE Washington, DC 20549-1090
BY ELECTRONIC SUBMISSION Elizabeth M. Murphy Secretary Securities and Exchange Commission 100 F Street, NE Washington, DC 20549-1090 David A. Stawick Secretary Commodity Futures Trading Commission Three
More informationGuidance for Industry
Guidance for Industry Fees-Exceed-the-Costs Waivers Under the Prescription Drug User Fee Act U.S. Department of Health and Human Services Office of Financial Management June 1999 User Fees Guidance for
More informationMarketed Unapproved Drugs: FDA to Take Immediate Enforcement Action at Any Time, Without Prior Notice
Marketed Unapproved Drugs: FDA to Take Immediate Enforcement Action at Any Time, Without Prior Notice Kurt R. Karst Hyman, Phelps & McNamara, P.C. 700 Thirteenth Street, N.W., Suite 1200 Washington, D.C.
More informationINTERNAL REVENUE SERVICE NATIONAL OFFICE TECHNICAL ADVICE MEMORANDUM. October 27, 2005
INTERNAL REVENUE SERVICE NATIONAL OFFICE TECHNICAL ADVICE MEMORANDUM Number: 200607020 Release Date: 2/17/2006 October 27, 2005 Index (UIL) No.: 833.03-03, 833.02-00 CASE-MIS No.: TAM-137654-05/FIP:B4
More informationThe opinions expressed herein are our own and do not necessarily reflect the views of The Johns Hopkins University.
Page 1 of 5 Johns Hopkins Center for a Livable Future 615 North Wolfe Street, W7010 Baltimore, MD 21205 July 12, 2012 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers
More informationTexas Natural Resource Conservation Commission Page 1 Chapter 15 - Fleet Vehicle Management Rule Log No. 2001-004-015-AD
Texas Natural Resource Conservation Commission Page 1 The Texas Natural Resource Conservation Commission (commission) adopts new Chapter 15, Fleet Vehicle Management, 15.1, Fleet Vehicle Management. Section
More informationRESPONSE OF THE UTILITY AIR REGULATORY GROUP TO EPA S CONSIDERATIONS IN THE DESIGN OF A PROGRAM TO REDUCE CARBON POLLUTION FROM EXISTING POWER PLANTS
Introduction RESPONSE OF THE UTILITY AIR REGULATORY GROUP TO EPA S CONSIDERATIONS IN THE DESIGN OF A PROGRAM TO REDUCE CARBON POLLUTION FROM EXISTING POWER PLANTS October 2013 On September 23, 2013, the
More informationRe: Minimum Requirements for Appraisal Management Companies
Legislative and Regulatory Activities Division Office of the Comptroller of the Currency 400 7 th Street SW., Suite 3E 218, Mail Stop 9W 11 Washington, DC 20219 Docket ID OCC 2014 0002 regs.comments@occ.treas.gov
More informationRules and Regulations: A primer on formal rulemaking processes and procedures in Colorado
Rules and Regulations: A primer on formal rulemaking processes and procedures in Colorado October 2012 George Lyford Page 1 of 9 Rulemaking the formal process of passing, or promulgating regulations is
More informationJuly 20, 2015. Submitted Electronically e-ori@dol.gov and e-oed@dol.gov
July 20, 2015 Submitted Electronically e-ori@dol.gov and e-oed@dol.gov Office of Regulations and Interpretations Office of Exemption Determinations Employee Benefits Security Administration U.S. Department
More informationUnofficial Consolidation January 1, 2015
This document is an unofficial consolidation of all amendments to National Instrument 21-101 Marketplace Operation, its Forms and its Companion Policy current to January 1, 201 This document is for reference
More informationMon. ICBA Summary of the Military Lending Act Updated Regulation. August 2015. Month Year. Contact:
ICBA Summary of the Military Lending Act Updated Regulation August 2015 Month Year Mon Contact: Joe Gormley Assistant Vice President & Regulatory Counsel joseph.gormley@icba.org www.icba.org ICBA Summary
More informationUNITED STATES OF AMERICA BEFORE THE FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES
UNITED STATES OF AMERICA BEFORE THE FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES In the Matter of Dendy Foods, Inc. d/b/a Grocer s Pride ADMINISTRATIVE COMPLAINT FOR CIVIL MONEY
More informationEITF Issue No. 06-4 Comment Letter No. 2A, p. 1
EITF Issue No. 06-4 Helping You Keep Your Best People SM 3600 American Blvd. West, Suite 200 952 893-6767 PHONE Minneapolis, MN 55431 952 893-6797 FAX www.clarkconsulting.com June 2, 2006 Mr. Lawrence
More informationFundamentals_Fernholz_1329. Introduction
Fundamentals_Fernholz_1329 Introduction The dormant commerce clause doctrine, while not explicitly mentioned in the Constitution, stands for the proposition that, in the absence of federal regulation,
More informationS T A T E O F T E N N E S S E E OFFICE OF THE ATTORNEY GENERAL PO BOX 20207 NASHVILLE, TENNESSEE 37202. April 16, 2007. Opinion No.
Cable Bill under the Contract Clause S T A T E O F T E N N E S S E E OFFICE OF THE ATTORNEY GENERAL PO BOX 20207 NASHVILLE, TENNESSEE 37202 April 16, 2007 Opinion No. 07-51 QUESTIONS House Bill 1421/Senate
More informationJuly 26, 2010. RESPA: Home Warranty Companies Payments to Real Estate Brokers and Agents Docket No. FR-5425-IA-01
American Bankers Association Consumer Mortgage Coalition Housing Policy Council of the Financial Services Roundtable Independent Community Bankers of America Mortgage Bankers Association July 26, 2010
More informationBEFORE THE HEARING OFFICER OF THE TAXATION AND REVENUE DEPARTMENT OF THE STATE OF NEW MEXICO
BEFORE THE HEARING OFFICER OF THE TAXATION AND REVENUE DEPARTMENT OF THE STATE OF NEW MEXICO IN THE MATTER OF THE PROTEST OF PITTSBURGH & MIDWAY COAL MINING COMPANY, I.D. NO. 01-765016-00, PROTEST TO DENIAL
More informationThis memorandum responds to your request for assistance. This advice may not be used or cited as precedent.
Office of Chief Counsel Internal Revenue Service Memorandum Release Number: 20073301F Release Date: 8/17/07 ------------------------: POSTF-123918-06 UILC: 162.00-00, 355.01-02 date: July 11, 2007 to:
More informationWhite Paper. Applying HIPAA s Framework to the Sale and Purchase of Healthcare Receivables
White Paper Applying HIPAA s Framework to the Sale and Purchase of Healthcare Receivables ACA International www.acainternational.org Final October 2007 I. About ACA Applying HIPAA s Framework to the Sale
More informationJohn H. O'Byrne Vice President and Anti-Money Laundering Compliance Officer New York Life Insurance Company
#30 Received Via Email November 25, 2002 To: From: regcomments@fincen.treas.gov John H. O'Byrne Vice President and Anti-Money Laundering Compliance Officer New York Life Insurance Company ATTN: Section
More informationMs. Johnson. Sincerely, Dr. Philip R. Day, Jr. NASFAA President and CEO
Docket No. R1353 Attn: Jennifer J. Johnson, Secretary Board of Governors of the Federal Reserve System 20 th Street and Constitution Ave. NW Washington, DC 20551 Ms. Johnson I am writing on behalf of the
More informationJRS Staffing Services--Costs
United States Government Accountability Office Washington, DC 20548 Comptroller General of the United States Decision Matter of: File: JRS Staffing Services--Costs Date: November 9, 2015 Jacqueline R.
More information